- About
- PsychU For You
- Topics
- Events
- Content
Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
About This Event
Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
This is a Live Event for PsychU members in the Cleveland, Ohio area.
In this presentation, the objectives are to:
- Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
- Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
- Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder
Cooper’s Hawk Winery & Restaurant – Orange Village
Doug McLaughlin, DO
Staff Psychiatrist, Cleveland Clinic; Clinical Assistant Professor of Psychiatry, Ohio University College of Osteopathic Medicine
MoreDr. Douglas McLaughlin is a board-certified psychiatrist who practices at Cleveland Clinic in Cleveland, Ohio. Dr. McLaughlin sees patients in both the inpatient and outpatient setting. His expertise is in mood disorders, anxiety disorders, ADHD, schizophrenia and dementia. Dr. McLaughlin is also a Clinical Assistant Professor of Psychiatry at Ohio University College of Osteopathic Medicine.
Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison
MoreDr. DiNapoli earned her PhD from the University of Alabama.Speaker Doug McLaughlin, DO is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Elizabeth DiNapoli, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Registration
PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.
- PsychU For You
